Lantern Pharma Inc. Excess Stock, Shares Issued
Lantern Pharma Inc. (LTRN) had Excess Stock, Shares Issued of 11.09 million shares as of 2021-12-31, per its 10-K filed 2022-03-10.
Discontinued › Balance Sheet › Equity › Excess Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:ExcessStockSharesIssued · last filed 2022-03-10
- 2021-12-31: Excess Stock, Shares Issued 11.09M shares.
- 2020-12-31: Excess Stock, Shares Issued 6.22M shares.
| Period end | Excess Stock, Shares Issued |
|---|---|
| 2021-12-31 | 11.09M shares 10-K · filed 2022-03-10 |
| 2020-12-31 | 6.22M shares 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |